Background: Fluid management in haemodialysis (HD) affects patient experience, morbidity and mortality. Standards for best practice are lacking. A national survey of the United Kingdom was undertaken to define prevalent practice. Methods: An online questionnaire was distributed to all UK renal centres. Results: Forty-five of 74 centres (173 dialysis units), serving 62% (n = 14,697) of UK HD population responded. Seventy-eight per cent had no agreed policy for managing fluid balance in patients on HD; 44% did not assess fluid status routinely. Clinical assessment was the norm; 27% used bio-impedance-based device. To achieve a target-weight, 53% reduced weight as far as tolerated. Twenty-two per cent measured residual renal function (RRF). Ninety-one per cent had no policy for fluid overload. Sixty-four per cent restricted salt and water. Ninety-three per cent used diuretics in patients with RRF. Thirty-eight per cent felt management was adequate; 77% felt there was a need for better evidence. Ninety-one per cent would participate in a study addressing this. Conclusion: There is an urgent need for establishing an evidence base on the optimal approaches to fluid management.

1.
Wizemann V, Wabel P, Chamney P, et al: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574-1579.
2.
Agarwal R: Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension 2010;56:512-517.
3.
Chazot C, Wabel P, Chamney P, et al: Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 2012;27:2404-2410.
4.
Stefánsson BV, Brunelli SM, Cabrera C, Rosenbaum D, Anum E, Ramakrishnan K, Jensen DE, Stålhammar NO: Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol 2014;9:2124-2132.
5.
Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM: Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol 2015;26:724-734.
6.
Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. J Am Soc Nephrol 2004;15:1061-1070.
7.
Vilar E, Farrington K: Emerging importance of residual renal function in end-stage renal failure. Semin Dial 2011;24:487-494.
8.
Hecking M, Karaboyas A, Antlanger M, et al: Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol 2013;38:78-90.
9.
Weiner DE, Brunelli SM, Hunt A, Schiller B, Glassock R, Maddux FW, Johnson D, Parker T, Nissenson A: Improving clinical outcomes among hemodialysis patients: a proposal for a ‘volume first' approach from the chief medical officers of US dialysis providers. Am J Kidney Dis 2014;64:685-695.
10.
Agarwal R, Weir MR: Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 2010;5:1255-1260.
11.
Chamney PW, Wabel P, Moissl UM, et al: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85:80-89.
12.
Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 2014;86:489-496.
13.
The 17th UK Renal Registry Report. https://www.renalreg.org/reports/2014-seventeenth-annual-report/ (accessed March 12, 2015).
14.
The 16th UK Renal Registry Report. https://www.renalreg.org/reports/2013-the-sixteenth-annual-report/ (accessed November 20, 2015).
15.
Moist LM, Port FK, Orzol SM, et al: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-564.
16.
Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD Study Group: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002;62:1046-1053.
17.
Daugirdas JT, Greene T, Rocco MV, et al: Effect of frequent hemodialysis on residual kidney function. Kidney Int 2013;83:949-958.
18.
Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C: Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 2012;32:767-776.
19.
Lin YF, Huang JW, Wu MS, et al: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 2009;14:59-64.
20.
Chandna SM, Farrington K: Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 2004;17:196-201.
21.
Lemes HP, Araujo S, Nascimento D, Cunha D, Garcia C, Queiroz V, Ferreira-Filho SR: Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis. Clin Exp Nephrol 2011;15:554-559.
22.
Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW: Diuretic use, residual renal function, and mortality among hemodialysis patients in the dialysis outcomes and practice pattern study (DOPPS). Am J Kidney Dis 2007;49:426-431.
23.
Renal Association Clinical Practice Guideline. 2013. http://www.renal.org/guidelines/modules/cardiovascular-disease-in-ckd (accessed May 3, 2015).
24.
Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, Taborsky P, Tetta C, Velasco N, Vlasak J, Zaluska W, Wizemann V: Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008;23:2965-2971.
25.
Luik AJ, van Kuijk WH, Spek J, de Heer F, van Bortel LM, Schiffers PM, van Hooff JP, Leunissen KM: Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis 1997;30:466-474.
26.
Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV: Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 2002;61:266-275.
27.
Inrig JK, Patel UD, Gillespie BS, Hasselblad V, Himmelfarb J, Reddan D, Lindsay RM, Winchester JF, Stivelman J, Toto R, Szczech LA: Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 2007;50:108-118, 118.e1-e4.
28.
Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A: Cardiac changes in uremia and their possible relation to cardiovascular instability on dialysis. Contrib Nephrol 1990;78:221-229.
29.
Poldermans D, Man in ‘t Veld AJ, Rambaldi R, Van Den Meiracker AH, Van Den Dorpel MA, Rocchi G, Boersma E, Bax JJ, Weimar W, Roelandt JR, Zietse R: Cardiac evaluation in hypotension-prone and hypotension-resistant hemodialysis patients. Kidney Int 1999;56:1905-1911.
30.
van der Sande FM, Mulder AW, Hoorntje SJ, Peels KH, van Kuijk WH, Kooman JP, Leunissen KM: The hemodynamic effect of different ultrafiltration rates in patients with cardiac failure and patients without cardiac failure: comparison between isolated ultrafiltration and ultrafiltration with dialysis. Clin Nephrol 1998;50:301-308.
31.
Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011;79:250-257.
32.
Agarwal R: Relative plasma volume monitoring for identifying volume-sensitive and resistant hypertension. Semin Dial 2010;23:462-465.
33.
Chazot C, Vo-Van C, Zaoui E, Vanel T, Hurot JM, Lorriaux C, Mayor B, Deleaval P, Jean G: Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients. Nephrol Dial Transplant 2011;26:2630-2634.
34.
Ishibe S, Peixoto AJ: Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice. Semin Dial 2004;17:37-43.
35.
Lopot F, Kotyk P, Bláha J, Forejt J: Use of continuous blood volume monitoring to detect inadequately high dry weight. Int J Artif Organs 1996;19:411-414.
36.
Steuer RH, Conis J: A new optical technique for monitoring hematocrit and circulating blood volume: its application in renal dialysis. Dial Transplant 1993;22:260-265.
37.
Franz M, Pohanka E, Tribl B, Woloszczuk W, Hörl WH: Living on chronic hemodialysis between dryness and fluid overload. Kidney Int Suppl 1997;59:S39-S42.
38.
Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G: Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356-363.
39.
Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E: Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 2013;61:957-965.
40.
Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, Covic AC: Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 2014;64:111-118.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.